Fulgent Genetics, Inc. (FLGT): Free Cash Flow
-$124.21M
Year ended 2025-12-31
-$103.79M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$124.21M | n/m | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | -$19.25M | n/m | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $4.80M | -98.0% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $234.75M | -54.4% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $514.76M | +387.9% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $105.50M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $4.33M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$3.00M | n/m | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | -$1.56M | n/m | 2019-03-22, From 2017-01-01 |
| 2016-12-31 | $617.0K | n/m | 2018-03-20, From 2016-01-01 |
| 2015-12-31 | -$3.07M | n/m | 2017-03-17, From 2015-01-01 |
| 2014-12-31 | -$5.13M | n/a | 2017-03-17, From 2014-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | -$124.21M | n/m |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $15.71M | n/m |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $28.33M | -22.5% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $126.63M | +98.5% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | -$299.92M | n/m |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $66.89M | n/m |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$233.07M | n/m |
| Biodesix Inc (BDSX) | 2025-12-31 | -$23.53M | n/m |
| Personalis, Inc. (PSNL) | 2025-12-31 | -$79.45M | n/m |
Compare FLGT, BLLN, CSTL, VCYT side by side · Screen every company in Services-Medical Laboratories ↗